Processing...
Processing...
Inmagic
®
Presto
Version 5.5 Build 151
Inmagic
®
Presto
Copyright © 2005-2021 by Lucidea Technologies Corp., Richmond BC Canada. All rights reserved.
Inmagic® and the Inmagic logo are registered trademarks of Lucidea Technologies Corp.
Unauthorized duplication or distribution is prohibited.
Other brand and product names are trademarks or registered trademarks of their respective holders. Use of any other product name does not imply endorsement of that product by Inmagic.
Third-party Licenses
Processing...
Processing...
Title
La chélation dans le traitement des troubles du spectre autistique (TSA)
Subtitle
Chelation for Autism Spectrum Disorder (ASD)
Author
Stephen James; Shawn W. Stevenson; Natalie Silove; Katrina Williams
Summary
This online article, in French, summarizes a review conducted to determine whether chelation is an effective treatment for people on the autism spectrum. It concludes that there is no clinical trial evidence to suggest that chelation is effective, while reports of serious adverse effects mean that risks of chelation outweigh benefits.
This resource is available in Croatian, English, French, Spanish and Japanese.
Cochrane is a "global independent network of researchers, professionals, patients, carers, and people interested in health." [Website] The network reviews evidence about health treatments.
Language
French
Subjects
Evaluating Research & Information
Publisher
Cochrane
DateModified
12/30/2022 7:36 PM EST